Literature DB >> 17169569

How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening.

Bernd Roehrig1, Klaus Hoeffken, Ludger Pientka, Ulrich Wedding.   

Abstract

Geriatric assessment (GA) in elderly cancer patients serves as screening instrument to identify patients who are vulnerable or frail. To reduce the diagnostic burden for patients and caregivers, we asked how many and which items of ADL and IADL questionnaires are necessary to identify those patients with limitations in the sum score of ADL or IADL. Data of 327 elderly patients (age>or=60 years), of whom 27.9% had limitations in ADL and 36.0% in IADL score, were entered in a forward selection model. Four out of ten items of ADL identified 95.3% of patients with limitations in ADL. Two out of eight items of IADL identified 97.4% of patients with limitations in IADL. The combined use of these items recognised 98.5% of patients with limitations in ADL or IADL score. If ADL and IADL scores are used for screening, we recommend an abbreviated version with 6 instead of 18 items.

Entities:  

Mesh:

Year:  2006        PMID: 17169569     DOI: 10.1016/j.critrevonc.2006.10.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  9 in total

1.  Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

Authors:  Maria De Santis; Joaquim Bellmunt; Graham Mead; J Martijn Kerst; Michael Leahy; Pablo Maroto; Thierry Gil; Sandrine Marreaud; Gedske Daugaard; Iwona Skoneczna; Sandra Collette; Julie Lorent; Ronald de Wit; Richard Sylvester
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries.

Authors:  Supriya Gupta Mohile; Ying Xian; William Dale; Susan G Fisher; Miriam Rodin; Gary R Morrow; Alfred Neugut; William Hall
Journal:  J Natl Cancer Inst       Date:  2009-07-28       Impact factor: 13.506

Review 3.  Advances in the pharmacological treatment of gastro-oesophageal cancer.

Authors:  Anna Dorothea Wagner; Ulrich Wedding
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Activity of daily living and its associated factors in war survivors with no visual acuity.

Authors:  Reza Amini; Hamid Haghani; Mehdi Masoomi; Shervin Assari
Journal:  J Res Med Sci       Date:  2010-07       Impact factor: 1.852

5.  Evaluation of properties of the Vestibular Disorders Activities of Daily Living Scale (Brazilian version) in an elderly population.

Authors:  Natalia A Ricci; Mayra C Aratani; Heloisa H Caovilla; Helen S Cohen; Fernando F Ganança
Journal:  Braz J Phys Ther       Date:  2014-03-19       Impact factor: 3.377

6.  Predictors of a Change and Correlation in Activities of Daily Living after Hip Fracture in Elderly Patients in a Community Hospital in Poland: A Six-Month Prospective Cohort Study.

Authors:  Maria Ganczak; Krzysztof Chrobrowski; Marcin Korzeń
Journal:  Int J Environ Res Public Health       Date:  2018-01-08       Impact factor: 3.390

Review 7.  Improving outcomes for older women with gynaecological malignancies.

Authors:  Lucy Dumas; Alistair Ring; John Butler; Tania Kalsi; Danielle Harari; Susana Banerjee
Journal:  Cancer Treat Rev       Date:  2016-08-29       Impact factor: 12.111

8.  Disabilities and activities of daily living among veterans with old hip disarticulation and transpelvic amputation.

Authors:  Amir Reza Kachooei; Mohamad Hosein Ebrahimzadeh; Mohamad Hallaj Moghadam; Asieh-Sadat Fattahi; Shiva Razi; Maryam Salehi; Hasan Azema
Journal:  Arch Trauma Res       Date:  2014-03-25

9.  Chronic Diseases and Associated Factors among Older Adults in Loja, Ecuador.

Authors:  Patricia Bonilla-Sierra; Ana-Magdalena Vargas-Martínez; Viviana Davalos-Batallas; Fatima Leon-Larios; Maria-de-Las-Mercedes Lomas-Campos
Journal:  Int J Environ Res Public Health       Date:  2020-06-04       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.